TLR activation pathways in HIV-1-exposed seronegative individuals
- PMID: 20124101
- DOI: 10.4049/jimmunol.0902463
TLR activation pathways in HIV-1-exposed seronegative individuals
Abstract
TLRs trigger innate immunity that recognizes conserved motifs of invading pathogens, resulting in cellular activation and release of inflammatory factors. The influence of TLR activation on resistance to HIV-1 infection has not been investigated in HIV-1 exposed seronegative (ESN) individuals. PBMCs isolated from heterosexually ESN individuals were stimulated with agonists specific for TLR3 (poly I:C), TLR4 (LPS), TLR7 (imiquimod), and TLR7/8 (ssRNA40). We evaluated expression of factors involved in TLR signaling cascades, production of downstream effector immune mediators, and TLR-expression in CD4+ and CD14+ cells. Results were compared with those obtained in healthy controls (HCs). ESN individuals showed: 1) comparable percentages of CD14+/TLR4+ and CD4+/TLR8+ CD14+/TLR8+ cells; 2) higher responsiveness to poly I:C, LPS, imiquimod, and ssRNA40 stimulation, associated with significantly increased production of IL-1beta, IL-6, TNF-alpha, and CCL3; 3) augmented expression of mRNA specific for other targets (CCL2, CSF3, CSF2, IL-1alpha, IL-8, IL-10, IL-12, cyclooxygenase 2) demonstrated by broader TLRs pathway expression analyses; and 4) increased MyD88/MyD88s(short) ratio, mainly following TLR7/8 stimulation. We also compared TLR-agonist-stimulated cytokine/chemokine production in CD14+ PBMCs and observed decreased IFN-beta production in ESN individuals compared with HCs upon TLR7/8-agonist stimulation. These data suggest that TLR stimulation in ESN individuals results in a more robust release of immunologic factors that can influence the induction of stronger adaptive antiviral immune responses and might represent a virus-exposure-induced innate immune protective phenotype against HIV-1.
Similar articles
-
Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.Liver Transpl. 2013 Oct;19(10):1099-107. doi: 10.1002/lt.23712. Liver Transpl. 2013. PMID: 23894100
-
The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.Br J Dermatol. 2015 Jan;172(1):48-55. doi: 10.1111/bjd.13214. Epub 2014 Nov 20. Br J Dermatol. 2015. PMID: 24976336
-
Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency.Clin Immunol. 2016 Aug;169:121-127. doi: 10.1016/j.clim.2016.07.001. Epub 2016 Jul 5. Clin Immunol. 2016. PMID: 27392462
-
Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy.Acta Biomater. 2019 Aug;94:82-96. doi: 10.1016/j.actbio.2019.05.043. Epub 2019 May 24. Acta Biomater. 2019. PMID: 31129358 Review.
-
A new role for myeloid HO-1 in the innate to adaptive crosstalk and immune homeostasis.Adv Exp Med Biol. 2011;780:101-11. doi: 10.1007/978-1-4419-5632-3_9. Adv Exp Med Biol. 2011. PMID: 21842368 Review.
Cited by
-
Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) Is Released in the Secretome of Activated MDMs and Reduces in vitro HIV-1 Infection.Front Immunol. 2019 Jul 16;10:1648. doi: 10.3389/fimmu.2019.01648. eCollection 2019. Front Immunol. 2019. PMID: 31379846 Free PMC article.
-
Antiviral factors and type I/III interferon expression associated with regulatory factors in the oral epithelial cells from HIV-1-serodiscordant couples.Sci Rep. 2016 May 11;6:25875. doi: 10.1038/srep25875. Sci Rep. 2016. PMID: 27168019 Free PMC article.
-
Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected.J Infect Dis. 2015 Mar 15;211(6):936-46. doi: 10.1093/infdis/jiu534. Epub 2014 Sep 23. J Infect Dis. 2015. PMID: 25249264 Free PMC article.
-
Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.AIDS Res Treat. 2020 Oct 27;2020:8672850. doi: 10.1155/2020/8672850. eCollection 2020. AIDS Res Treat. 2020. PMID: 33178456 Free PMC article. Review.
-
Neither microbial translocation nor TLR responsiveness are likely explanations for preexisting immune activation in women who subsequently acquired HIV in CAPRISA 004.J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):294-8. doi: 10.1097/QAI.0b013e31828e604b. J Acquir Immune Defic Syndr. 2013. PMID: 23481666 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous